Lymphoma Cancer | Tumor

5 Recent Cancer Drug Approvals Patients May Have Missed

February 26th 2021, 7:00pm

Article

Throughout the winter, the FDA has continued to approve several new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.

Above the Surface: A Discussion About Cutaneous T-Cell Lymphoma

February 20th 2021, 2:00pm

Article

As part of its Speaking Out video series, CURE® spoke with Dr. Steven M. Horwitz on behalf of the Cutaneous Lymphoma Foundation about cutaneous T-cell lymphoma and options for treatment.

Advocating for Herself Amid Treatment for a Rare Cancer

February 15th 2021, 1:00pm

Article

One patient with breast implant-associated anaplastic large cell lymphoma spoke out for herself throughout therapy — and encourages other patients do the same.

CAR-T Cell Therapy Receives FDA Approval to Treat Certain Types of Large B-Cell Lymphoma

February 5th 2021, 9:24pm

Article

The Food and Drug Administration on Friday approved Breyanzi, a cell-based gene therapy, for the treatment of adults with certain types of large B-cell lymphoma.

Learning the Basics of a Rare Disease: Cutaneous T-Cell Lymphoma

January 19th 2021, 2:00pm

Video

On behalf of the Cutaneous Lymphoma Foundation, CURE spoke with Drs. Steven M. Horwitz and Lauren Pinter-Brown about the basics of cutaneous T-cell lymphoma, as well as current treatment options and those being evaluated for the rare disease.

Significant Number of Patients With Blood Cancers Deal With Depression or Anxiety Before or After Diagnosis, Highlighting ‘Critical’ Need for Mental Health Screening and Management

December 8th 2020, 4:00pm

Article

This data, according to a resident physician at Brigham and Women’s Hospital, highlights the need for systematic mental health screening and management for individuals with blood cancers.

Patients With Aggressive Lymphomas Experience Major Quality of Life Improvements 1 Year After Diagnosis

December 7th 2020, 10:00pm

Article

Patients with aggressive lymphomas experienced sharp increases in quality of life from time of diagnosis until one year later and continued to see improvements for almost a decade.

Poteligeo May Result in Antitumor Activity in Adult T-Cell Leukemia/Lymphoma

December 2nd 2020, 2:00pm

Article

Study results also determined that immune system status before treatment may predict outcomes post-treatment.

Smiling Through Cancer Treatment Amid the COVID-19 Pandemic

November 26th 2020, 4:00pm

Podcast

In this episode of the “CURE Talks Cancer” podcast, we spoke with a teenager who was diagnosed with Hodgkin lymphoma at the start of the COVID-19 pandemic. We talked about her cancer journey, what it was like to receive treatment during the pandemic, and more.

CAR T Therapy for Relapsed/Refractory DLBCL: Brian’s Story

November 25th 2020, 5:00am

Video